Inhibition of XPO1 may influence many inflammatory/immune pathways associated with neurological diseases, such as Nrf2, FOXOs, and NF‐κB signaling pathways (Archbold et al., 2018). This evidence concerns the gene NFKB1 and nervous system disorder.